Senator Patty Murray, D-Washington, has questioned new Centers for Disease Control and Prevention director Brenda Fitzgeralds over financial holdings that could prevent her from talking about cancer and prescription drug monitoring programs.

A spate of hospital deals stands to further remake the U.S. health-care landscape, pushing up prices for consumers and insurers and changing how individuals get care.

The nations most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change.

According to a New York Times/ProPublica report, Americans may be overpaying for as much as one in every 10 prescriptions by using their insurance instead of seeking out an alternate source and paying cash.